Fundraising Fox

Ascendiapharma

North Brunswick, US · Delaware corporation · 1 known investors

ascendiapharma.com ↗

Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization. The company specializes in solving drug development challenges for small molecules, biologics, and gene delivery applications.

Advanced ManufacturingBiotechHealthtechMedical Devicesin /ascendia-pharmaceuticals-llc

Founders & leadership

JH
Jingjun HuangExecutive Officer, Director
JG
James GaleDirector
RB
Robert BloderDirector
MB
Michael BogdaDirector
SL
Shoufeng LiDirector
TO
Theron OdlaugDirector

Investors · 1

Signet Healthcare PartnersNew York · $10M – $50M

Reported raises · per SEC filings

Form D private placements
▶$4.1MraisedJul 2026 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jingjun HuangDirector
  • Michael BogdaDirector
  • James GaleDirector
  • Robert BloderDirector
  • Theron OdlaugDirector
  • Shoufeng LiDirector
Offering amount
$4.1M
Amount sold
$4.1M
Minimum investment
$500K
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedJun 2025 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Shoufeng LiDirector
  • James GaleDirector
  • Jingjun HuangExecutive Officer, Director
  • Theron OdlaugDirector
  • Robert BloderDirector
Offering amount
$2.5M
Amount sold
$2.5M
Minimum investment
$100K
First sale
May 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedOct 2024 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James GaleDirector
  • Shoufeng LiDirector
  • Jingjun HuangExecutive Officer, Director
  • Robert BloderDirector
  • Theron OdlaugDirector
Offering amount
$2.5M
Amount sold
$2.5M
Minimum investment
$475.1K
First sale
Sep 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedJul 2022 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Colin FosterDirector
  • Theron OdlaugDirector
  • Robert BloderDirector
  • James GaleDirector
  • Jingjun HuangExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$2.5M
Minimum investment
$475K
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedApr 2021 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jingjun HuangExecutive Officer, Director
Offering amount
$10M
Amount sold
$5M
Minimum investment
$950K
Sales commissions
$300K
Placement agents
Wombat Capital Markets LLC
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.